Article Text

Download PDFPDF
Exercise and the heart: unmasking Mr Hyde
  1. Eduard Guasch,
  2. Lluís Mont
  1. Thorax Institute, Unitat de Fibril·lació Auricular, Hospital Clínic, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain
  1. Correspondence to Dr Lluís Mont, Institut Clínic del Tòrax, Hospital Clínic de Barcelona, C/Villarroel 170, escala 1, planta 6, Barcelona, Catalonia 08036, Spain; lmont{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

As physicians, we often face patients with cardiovascular risk factors or different kinds of heart disease. We prescribe statins, ACE inhibitors or β-blockers, but also (should) encourage our patients to engage in regular physical activity to reduce cardiovascular disease burden. Physical exercise, as a part of cardiac rehabilitation or a primary prevention programme, is seemingly one of a kind. ‘For most health outcomes, additional benefits occur as the amount of physical activity increases through higher intensity, greater frequency, and/or longer duration’.1 No other known therapy offers such advantageous characteristics. This even led some researchers to speculate, some 40 years ago, that marathon runners were immune to atherosclerosis.2 Running a marathon was quite unusual at that time, and cardiovascular adaptation to such a high load of exercise had been scarcely explored. Since then, the late 70s, the number of non-professional runners finishing a marathon has increased 20-fold, and current observational studies are jeopardising the notion of exercise as risk-free. Increased sudden death risk during exercise bouts is well established but extremely rare. An evolving core of evidence supports the hypothesis that regular exercise increases the risk of atrial fibrillation (AF), ventricular arrhythmias or even ischaemic heart disease.3 How do these findings fit with the well-known benefits of exercise? Two papers explore this subject4 ,5 and provide important insights.

By assessing outcomes such as AF incidence4 and cardiovascular or total mortality,5 both groups elegantly suggest in two large cohorts that exercise intensity and duration are key players in this association. They describe a similar U-shaped or reverse J-shaped pattern for the dose–response effect of exercise: maximum cardiovascular benefits are obtained if performed at moderate doses, while these benefits are lost with (very) high-intensity and prolonged efforts.

Both groups took previously collected data on exercise performance …

View Full Text


  • Contributors EG and LM equally wrote and approved the manuscript.

  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles